$40 Billion COVID Vaccine Market in 2021: These 3 Stocks Are Likely to Be the Biggest Winners
From zero to $40 billion in a year: That's what Bernstein analyst Ronny Gal expects for the COVID-19 vaccine market. Gal projects 2021 sales of coronavirus vaccines will approach that huge number, with the market being split among five drugmakers.
The companies with the highest sales dollars won't necessarily be the best-performing stocks, though. Relatively smaller biotech stocks with vaccines on the market will almost certainly deliver greater gains than huge drugmakers will. With that in mind, here are the three stocks that are likely to be the biggest winners from the massive COVID vaccine market that's on the way.
Image source: Getty Images.
Source Fool.com
